Large-scale testing (Phase 3)Study completedNCT02329223
What this trial is testing
Study of Efficacy and Safety of Omalizumab in Refractory Chronic Spontaneous Urticaria Patients
Who this might be right for
Chronic Spontaneous Uriticaria
Novartis Pharmaceuticals 218